Gene expression: Biomarker of antidepressant therapy?
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
While antidepressant therapy is an essential treatment of major depression, a substantial group of treated patients do not respond to therapy, or suffer from severe side effects. Moreover, the time of onset of the clinical improvement is often delayed. Antidepressants as currently available usually enhance serotonergic, noradrenergic and dopaminergic neurotransmission and may contribute to the inadequate remission rates for major depression. Therefore biomarkers enabling the identification of subgroups of patients and also finding unprecedented targets would provide the basis for personalized medication and thus improve treatment efficacy and reduce side effects. Several pharmacogenetic studies on antidepressant treatment response using single nucleotide polymorphism (SNPs) mapping have been performed but provided only modest findings. Therefore the analysis of gene expression to integrate genomic activity and environmental effects promises a new approach to cope with the complexity of factors influencing antidepressant treatment. Here gene expression studies focusing on candidate genes and genome-wide approaches using RNA derived from peripheral blood cells are reviewed. The most promising findings exist for hypothalamic-pituitary-adrenal (HPA) axis, inflammation and neuroplasticity related genes. However, straightforward translation into tailored treatment is still unlikely. Contradictory results limit the clinical use of the findings. Future studies are necessary, which could include functional analysis and consider gene-environment interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · cited 1×
“Major depression is predicted to become a leading cause of morbidity worldwide, negatively affecting a patient ’ s mood, cognition, social relations, and potentially resulting in suicidal behavior (Ustun et al., 2004).”
BackgroundGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“The glucocorticoid receptor (GR) plays a crucial role in mediating the negative feedback regulation of the HPA axis (de Kloet et al., 2005; Pariante & Miller, 2001).”
BackgroundDepression as a predictor for coronary heart disease
Rugulies, R. (2002) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(02)00439-7 · Cited by 1,110 · cited 1×
“There was also a decreased number of circulating EPCs in depressed patients, which was associated with cardiovascular risk factors and could provide a link between major depression and cardiovascular disease (Rugulies, 2002).”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 2×
“Within the top genes differentially regulated by dexamethasone in both cohorts was FKBP5, previously reported to be associated with stress-related disorders and of importance to the HPA axis regulation (Binder, 2009).”
BackgroundCastrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M., & Serretti, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.116 · Cited by 450 · cited 1×
“The rate-limiting enzyme tryptophan hydroxylase (TPH1) involved in the synthesis of serotonin, which was also associated with treatment response to antidepressive agents (Kato & Serretti, 2010), was signifi cantly up-regulated after 8 weeks of treatment.”
BackgroundCattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.191 · Cited by 436
Rush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S., Mundt, J. C., Shores-Wilson, K., Biggs, M. M., Woo, A., Nierenberg, A. A., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.022 · Cited by 385 · cited 1×
“…large US National Institute of Mental Healthfunded Sequenced Treatment Alternatives to Relieve Depression (STAR ∗ D) trial, which enrolled over 1,400 participants treated only with one drug, citalopram (Rush et al., 2006), no genome-wide threshold for signifi cance was met (Garriock et al., 2010).”
BackgroundThe Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 1×
“In addition, CREB1 has also been implicated in antidepressant response (Blendy, 2006), and neuronal plasticity as well as in hippocampus-dependent memory process (Weeber et al., 2002).”
BackgroundPadmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336 · cited 1×
“…post-traumatic stress disorder (Mehta et al., 2011; Segman et al., 2005; Yehuda et al., 2009), schizophrenia (Kurian et al., 2011), and bipolar disorder (Le-Niculescu et al., 2009; Padmos et al., 2008), and major depression (Menke, Arloth et al., 2012; Segman et al., 2010; Spijker et al., 2010).”
BackgroundYehuda, R., Cai, G., Golier, J. A., Sarapas, C., Galea, S., Ising, M., Rein, T., Schmeidler, J., Müller-Myhsok, B., Holsboer, F., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.034 · Cited by 294 · cited 1×
“…’ s (Scherzer et al., 2007), Huntington ’ s disease (Borovecki et al., 2005), post-traumatic stress disorder (Mehta et al., 2011; Segman et al., 2005; Yehuda et al., 2009), schizophrenia (Kurian et al., 2011), and bipolar disorder (Le-Niculescu et al., 2009; Padmos et al., 2008), and major…”
BackgroundSegman, R. H., Shefi, N., Goltser-Dubner, T., Friedman, N., Kaminski, N., & Shalev, A. Y. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001636 · Cited by 281 · cited 1×
“…with Parkinson ’ s (Scherzer et al., 2007), Huntington ’ s disease (Borovecki et al., 2005), post-traumatic stress disorder (Mehta et al., 2011; Segman et al., 2005; Yehuda et al., 2009), schizophrenia (Kurian et al., 2011), and bipolar disorder (Le-Niculescu et al., 2009; Padmos et al.,…”
Genetic predictors of response to antidepressants in the GENDEP project
Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., Hauser, J., Maier, W., Kozel, D., Henigsberg, N., et al. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.12 · Cited by 226 · cited 2×
“In the Genome-based Therapeutic Drugs for Depression (GENDEP) project (Uher et al., 2009), a multicentre pharmacogenetic study with depressed patients treated with either escitalopram or nortriptyline, a signifi cant reduction of baseline FKBP5 RNA levels in peripheral blood after successful…”
MethodMehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · cited 1×
“…including patients with Parkinson ’ s (Scherzer et al., 2007), Huntington ’ s disease (Borovecki et al., 2005), post-traumatic stress disorder (Mehta et al., 2011; Segman et al., 2005; Yehuda et al., 2009), schizophrenia (Kurian et al., 2011), and bipolar disorder (Le-Niculescu et al.,…”
BackgroundMenke, A., Arloth, J., Pütz, B., Weber, P., Klengel, T., Mehta, D., Gonik, M., Rex-Haffner, M., Rubel, J., Uhr, M., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.331 · Cited by 177
Self-citationHow can we realize the promise of personalized antidepressant medicines?
Holsboer, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2453 · Cited by 177 · cited 2×
“…of antidepressants into the clinic in the 1950s with the serendipitous discovery of the tricyclic antidepressant (TCA) imipramine, refi ned successor drugs have resulted mainly in fewer side effects, while only little improvement in clinical effi cacy could be achieved (Holsboer, 2008).”
BackgroundMenke, A., Klengel, T., Rubel, J., Brückl, T., Pfister, H., Lucae, S., Uhr, M., Holsboer, F., & Binder, E. B. (2013) · Genes, Brain and Behavior · doi:10.1111/gbb.12026 · Cited by 151 · cited 2×
“In addition, the robust fi ndings of HPA axis-related genes with GR impairment and differences in FKBP5 RNA expression were found in candidate approaches (Matsubara et al., 2006; Menke et al., 2013) as well as in genome-wide analyses (Menke, Arloth et al., 2012).”
BackgroundSelf-citationPandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Zhang, H., & Pavuluri, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.003 · Cited by 118 · cited 2×
“BDNF RNA expression in peripheral lymphocytes was decreased in adult and pediatric depressed patients compared to healthy controls (Pandey et al., 2010).”
BackgroundAltered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression
Iga, J.-I., Ueno, S.-I., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., Song, H., & Ohmori, T. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.014 · Cited by 105
Reduced Glucocorticoid Receptor α Expression in Mood Disorder Patients and First-Degree Relatives
Matsubara, T., Funato, H., Kobayashi, A., Nobumoto, M., & Watanabe, Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.026 · Cited by 94 · cited 3×
“In addition, the robust fi ndings of HPA axis-related genes with GR impairment and differences in FKBP5 RNA expression were found in candidate approaches (Matsubara et al., 2006; Menke et al., 2013) as well as in genome-wide analyses (Menke, Arloth et al., 2012).”
Imipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M., & Nakamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12039fp · Cited by 70 · cited 1×
“The TCA imipramine elevated BDNF RNA in cortex and hippocampus of rodents (Rogoz et al., 2007) and in cultured rat brain astrocytes (Takano et al., 2012).”
BackgroundMurphy, G. M., Sarginson, J. E., Ryan, H. S., O’Hara, R., Schatzberg, A. F., & Lazzeroni, L. C. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328360b175 · Cited by 50
Cited by
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Epigenetic alterations in depression and antidepressant treatment
Menke, A., & Binder, E. B. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/amenke · Cited by 161
Self-citationRedei, E. E., Andrus, B. M., Kwasny, M. J., Seok, J., Cai, X., Ho, J., & Mohr, D. C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.66 · Cited by 83
Leistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
Self-citationMenke, A. (2018) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s146110 · Cited by 41
“variants predisposing to MDD and early adversity as a major environmental factor.(129,130) Common approaches for”
BackgroundSelf-citation
Metadata
- Authors
- Menke, A.
- Venue
- International Review of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2013-10
- Volume
- 25
- Issue
- 5
- Pages
- 579-591
- ISSN
- 0954-0261 (ISSN-L)
- 1369-1627
- OpenAlex
- W2146640338
- Cited by
- 25
- References
- 24
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.